eMed logo

eMed

Challenger

Raised $200M Series A (Mar 2026) at $2B+ valuation led by AON Consulting. 91%+ medication adherence. GLP-1 benefits platform for employers. Linda Yaccarino CEO.

Best for: Metabolic Health
54
AI Score
Grade C
AI Visibility Score (Beta)
HealthcareMetabolic HealthWebsiteUpdated November 2026

Brand Intelligence Graph

Capabilities
Metabolic Health

Company Overview

About eMed

eMed is a GLP-1 and metabolic health benefits platform built specifically for employer-sponsored health plans, the fastest-growing category in US workplace benefits. The company raised $200 million in Series A financing in March 2026 at a $2 billion+ valuation led by AON Consulting, with backing from Linda Yaccarino (former Twitter/X CEO, now eMed CEO) and Tom Brady. Claiming 91%+ medication adherence rates, eMed positions itself as the most effective GLP-1 benefits program available to employers.

Business Model & Competitive Advantage

The platform's capitated pricing model shifts financial risk from employers to eMed — charging a fixed fee per member regardless of how many GLP-1 prescriptions are written — which makes total cost predictable for HR and benefits teams wrestling with runaway drug spend. GLP-1 medications (Ozempic, Wegovy) have become the most requested workplace health benefit in the US, and their list prices create budget pressure that employers urgently need managed.

Competitive Landscape 2025–2026

eMed combines clinical oversight (prescribers, pharmacists, registered dietitians) with behavioral coaching and medication management to improve outcomes and reduce GLP-1 discontinuation, which runs 50-70% in typical commercial populations. The company's approach is to treat GLP-1 therapy as a managed clinical program rather than a pharmacy benefit, driving the adherence rates it claims as a differentiator.

Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

eMed is an established challenger with significant market presence and competitive offerings in Digital Health.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

54
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Zocdoc logo

Zocdoc

HealthTech
AnalyticsB2bB2cHealthtechMarketplaceMobile FirstPlatformSaas

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati

Noom logo

Noom

Healthcare
StartupB2cHealthtechMobile FirstPlatform

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha

Hims & Hers logo

Hims & Hers

Healthcare
HealthtechB2cMobile FirstGlobal

Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for condi

Doximity logo

Doximity

HealthTech
HealthtechSaasB2bB2cStartupPlatformAi PoweredMobile First

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic

Headspace logo

Headspace

Healthcare
B2cHealthtechStartupMobile FirstB2b2cScaleup

Headspace is a mental wellness company founded in 2010 by Andy Puddicombe and Rich Pierson that has grown into one of the most widely used mindfulness and meditation apps globally. The platform offers

Persivia logo

Persivia

Digital Health
B2cHealthtechMobile First

Persivia is a unified AI healthcare platform spanning care management, population health analytics, and revenue cycle operations — one of the few integrated platforms that addresses both the clinical

Compare eMed with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For eMed

Claim This Profile

Are you from eMed? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.

Claim eMed Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention eMed vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →